… -based drug-target interaction model called Molecule Transformer-Drug Target Interaction (…
) to identify commercially available drugs that could act on viral proteins of SARS-CoV-2. The …

… protein drug targets of SARS-CoV-2 and their structures, including the drug target class and
its … We have also discussed several drug discovery approaches and associated protein drug …

… of action may be a practical therapeutic strategy for the treatment of severe COVID-19. …
therapeutics against SARS-CoV-2. This review highlights the anti–SARS-CoV-2 drug targets and …

… of candidate repurposable drugs and potential drug combinations targeting SARS-CoV-2
using disease-related molecular networks. A systematic drug repurposing approach has been …

… RNA polymerase is treated as a principal target for the SARS-CoV2. Its similarity with other
viruses allows us to test the existing antiviral molecule against COVID19. Nucleotide analogs, …

… and targets for further in vitro and in vivo studies of SARS-CoV-2, new insights for those …
drug repositioning candidates and targets for further in vitro and in vivo studies of SARS-CoV-2…

… SARS-CoV-2 drug target was screened for probable drug … and SWEETLEAD drug database
(Centre for Drug Evaluation … used for drug repurposing studies against the drug target 3CL …

… confidence protein–protein interactions between SARS-CoV-2 and human proteins. Among
… targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug …

… Identification of existing drugs targeting SARS-CoV-2 human host factors. To identify small
molecules targeting human proteins in the SARS-CoV-2 interactome, we sought ligands …

… (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and …
drugs targeting 2019-nCoV/SARS-CoV-2. Drug repurposing, representing as an effective drug …